COVID-19: The Race for a Cure

COVID-19 is changing many aspects of modern life, and many of those changes will have long-lasting effects. Drug development is one of those aspects. In this edition of CompTalks, Phil Walls will take us on a Race for the Cure as he examines how both the pandemic as well as politics have influenced drug and vaccine development for the coronavirus. Walls will challenge the audience to think of drug development in a risk versus benefit model where speed to market comes with higher risks – but perhaps justifiable when lives are at stake.

Phil Walls
Chief Clinical Officer, myMatrixx

Phil Walls is the Chief Clinical Officer for myMatrixx. He oversees all aspects of myMatrixx’s clinical program, including drug utilization review, formulary management, drug regimen reviews and targeted intervention with prescribing physicians. Phil is a clinical pharmacist with over 40 years of experience in pharmacy, healthcare informatics and workers’ comp. Phil is a highly regarded clinical pharmacist and frequent speaker. This is his passion and his priority — educating people and patients on the dangers of opioid abuse and the epidemic that is devastating the lives of so many people across our country.

Phil Walls can be reached at [email protected].

CompTalks are a presentation of the National Workers’ Compensation and Disability Conference – National Comp. CompTalks are short-format educational presentations that fit our busy schedules, delivered by voices throughout the industry. This series will offer a mix of thought-provoking opinions, insider perspectives and useful strategies you can bring back to your team to spark further discussion — presented on-demand.

This new feature is a complement to the National Comp conference program. Register now and save the date for our 2021 event, Oct. 20-22 at Mandalay Bay in Las Vegas.

REGISTER NOW